Artal Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $12.9M | Hold |
|
|||||
|
2024
Q1 | $13.4M | Hold |
|
|||||
|
2023
Q4 | $19.5M | Buy |
|
|||||
|
2023
Q3 | $5.83M | Hold |
|
|||||
|
2023
Q2 | $4.65M | Hold |
|
|||||
|
2023
Q1 | $3.94M | Buy |
|
|||||
|
2022
Q4 | $5.25M | Hold |
|
|||||
|
2022
Q3 | $9.43M | Buy |
|
|||||
|
2022
Q2 | $3.85M | Buy |
|
|||||
|
2022
Q1 | $4.17M | Buy |
|
|||||
|
2021
Q4 | $9.78M | Buy |
|
|||||
|
2021
Q3 | $8.94M | Buy |
|
|||||
|
2021
Q2 | $9.27M | Buy |
|
|||||
|
2021
Q1 | $7.67M | Buy |
|
|||||
|
2020
Q4 | $8.14M | Buy |
|
|||||
|
2020
Q3 | $4.12M | Sell |
|
|||||
|
2020
Q2 | $5.22M | Sell |
|
|||||
|
2020
Q1 | $3M | Buy |
|